Attention Deficit Disorder With Hyperactivity Clinical Trial
Official title:
Multisite Study of School Based Treatment Approaches for ADHD Adolescents
This study will compare the efficacy and cost effectiveness of two methods of treating adolescents with attention deficit hyperactivity disorder in school.
Attention deficit hyperactivity disorder (ADHD) is characterized by inattention,
hyperactivity, and impulsivity. Approximately 50% to 70% of children who had ADHD continue
to meet its criteria in adolescence, but the problems stemming from adolescent ADHD can be
more serious—including an increased risk of substance use, delinquency, academic failure,
serious social impairment, and legal problems. Problems in school more than double when
students with ADHD move from elementary school to middle and high school.
Treating ADHD with medications alone is often ineffective, but adding other methods, such as
behavioral treatments, may be beneficial. Researchers have developed a psychosocial
treatment for adolescents with ADHD, called the Challenging Horizons Program (CHP), that is
delivered in school and targets social impairment, family conflict, and academic failure.
Two versions of CHP were developed, an after-school model and a consultation model. The
after-school model involves 2 to 3 days of individualized treatment per week and has a
higher cost than the consultation model because it involves hiring specialized counseling
staff and finding space to house the program after school. The consultation model involves
teaching CHP intervention strategies to school staff, who then mentor students with ADHD and
deliver interventions as needed to solve problems. This model is less expensive, but it does
not deliver treatment as often or consistently as the after-school model. This study will
compare the after-school and consultation models of the CHP to determine their relative
efficacy and cost effectiveness. The study will also evaluate factors that may predict which
adolescents would benefit most from either of the two models.
Participation in this study will last a full school year. Participants from schools taking
part will be randomly assigned to one of three groups: after-school CHP, consultation CHP,
or standard community care. Participants receiving after-school CHP will attend two 2.5-hour
after-school sessions per week in which they will work with counselors on homework
management, educational skills, and interpersonal skills. Participants receiving
consultation CHP will be assigned a teacher mentor (who will volunteer to work with the
student), and the mentor and student will meet as needed. A study clinician will provide
support to the teacher mentors, who will learn the same interventions as counselors in the
after-school condition. Participants in the community care condition will not receive any
intervention but will receive a list of community psychosocial and medical service providers
for children and their families. All participants will undergo study assessments
pre-treatment; in November, January, and March of the school year; post-treatment; and at a
6-month follow-up. Assessments will include questionnaires and clinical interviews completed
by student, their parents, and their teachers. ADHD symptoms, academic performance, relevant
skills of adolescents, and program costs will be assessed.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00202605 -
Safety and Efficacy of SPD465 in Adults With ADHD
|
Phase 2 | |
Not yet recruiting |
NCT02677519 -
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
|
Phase 4 | |
Completed |
NCT02730572 -
Concerta (Methylphenidate) -To-Generic Switch Study
|
N/A | |
Completed |
NCT01681082 -
Psychological Effects of Tai Chi Training
|
N/A | |
Active, not recruiting |
NCT01330693 -
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
|
Phase 3 | |
Completed |
NCT00830700 -
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
|
N/A | |
Completed |
NCT01012622 -
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
|
Phase 4 | |
Completed |
NCT00626236 -
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
|
Phase 2 | |
Completed |
NCT00598182 -
Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
|
N/A | |
Completed |
NCT00381407 -
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00178503 -
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
|
Phase 2/Phase 3 | |
Completed |
NCT00247572 -
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
|
Phase 2 | |
Completed |
NCT00118911 -
Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00218322 -
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
|
Phase 4 | |
Completed |
NCT00557011 -
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
|
Phase 2 | |
Completed |
NCT00071656 -
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
|
N/A | |
Active, not recruiting |
NCT00057668 -
Preventing Behavior Problems in Children With ADHD
|
Phase 2 | |
Completed |
NCT00050622 -
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT00050050 -
Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT00031395 -
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
|
Phase 3 |